Literature DB >> 17509550

Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis.

Chandra S Lal, Anil Kumar, Sanjay Kumar, Krishna Pandey, Nawin Kumar, Sanjiva Bimal, Prabhat K Sinha, Pradeep Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17509550     DOI： 10.1016/j.cca.2007.04.007

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  16 in total

1.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

2.  Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.

Authors:  J Ghosh; C S Lal; K Pandey; V N R Das; P Das; K Roychoudhury; S Roy
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  Canine visceral leishmaniosis: the relationship of blood serum thyroid hormones, lipids, and lipoproteins with clinical status.

Authors:  M Khaleghi Einakchi; N Sedaghat Sharifi; J Khoshnegah; M Heidarpour
Journal:  Parasitol Res       Date:  2018-09-27       Impact factor: 2.289

4.  Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.

Authors:  Stella Costa Silva; Débora Faria Silva; Tamires Cunha Almeida; Fernanda Barçante Perasoli; André Talvani Pedrosa da Silva; Glenda Nicioli da Silva; Simone Aparecida Rezende
Journal:  Parasitol Res       Date:  2018-06-25       Impact factor: 2.289

5.  Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis.

Authors:  C S Lal; R B Verma; N Verma; N A Siddiqui; V N Rabidas; K Pandey; D Singh; S Kumar; R K Paswan; A Kumari; P Sinha; P Das
Journal:  Infection       Date:  2015-07-10       Impact factor: 3.553

6.  Association between Hypertriglyceridemia and Disease Severity in Visceral Leishmaniasis.

Authors:  Mariana Garcez Varela; Mariana de Oliveira Bezerra; Felipe Vieira Santana; Marcos Couto Gomes; Pedro Ribeiro de Jesus Almeida; Geydson Silveira da Cruz; Enaldo Vieira de Melo; Paulo Roberto de Oliveira Costa; Fabrícia Alvisi de Oliveira; Amélia Ribeiro de Jesus; Roque Pacheco de Almeida
Journal:  Am J Trop Med Hyg       Date:  2021-11-22       Impact factor: 2.345

7.  Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing.

Authors:  June Ghosh; Rajan Guha; Shantanabha Das; Syamal Roy
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

8.  Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function.

Authors:  Abdur Rub; Ranadhir Dey; Meenakshi Jadhav; Rohan Kamat; Santhosh Chakkaramakkil; Subrata Majumdar; Robin Mukhopadhyaya; Bhaskar Saha
Journal:  Nat Immunol       Date:  2009-02-08       Impact factor: 25.606

9.  Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.

Authors:  June Ghosh; Mainak Bose; Syamal Roy; Suvendra N Bhattacharyya
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

10.  Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis.

Authors:  Neena Verma; Chandra Shekhar Lal; Vidyanand Rabidas; Krishna Pandey; Dharmendra Singh; Sanjay Kumar; Rakesh Bihari Verma; Pradeep Das
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.